Wendy Stock to Immunoconjugates
This is a "connection" page, showing publications Wendy Stock has written about Immunoconjugates.
Connection Strength
0.333
-
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study. Leuk Res. 2020 08; 95:106385.
Score: 0.168
-
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Adv. 2020 02 11; 4(3):449-457.
Score: 0.165